Skip to main content
Christine Kempton, MD, Hematology, Atlanta, GA

Christine L Kempton MD MSc

Hematology•Atlanta, GA

Clotting Disorder, Hemophilia & Bleeding Disorder

Professor, Department of Hematology and Medical Oncology

Join to view full profile

  • 1365 Clifton Rd NEAtlanta, GA 30322

  • Phone+1 404-778-1900

Dr. Kempton is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Kempton's full profileAlready have an account?

Education & Training

  • University of North Carolina Hospitals
    University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 2001 - 2004
  • Oregon Health & Science University (OHSU Health)
    Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 1997 - 2000
  • Mayo Clinic College of Medicine
    Mayo Clinic College of MedicineClass of 1997

Certifications & Licensure

  • OR State Medical License
    OR State Medical License 1998 - Present
  • GA State Medical License
    GA State Medical License 2005 - 2027
  • NC State Medical License
    NC State Medical License 2001 - 2005
  • Hematology
    American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 2 Certification HealtheLife and PowerChart, Cerner Corporation, 2013, 2016-2017
  • CMS Meaningful Use Stage 2 Certification PowerChart (All CQM's), Cerner Corporation, 2013, 2016-2017
  • CMS Meaningful Use Stage 2 Certification PowerChart (Clinical), Cerner Corporation, 2013, 2016-2017

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Emicizumab Prophylaxis in Patients Who Have Hemophilia A Without Inhibitors  
    Christine Kempton, Gallia G Levy, Michael U Callaghan, The New England Journal of Medicine

Abstracts/Posters

  • Bone and Joint Health Markers in Persons with Hemophilia A (PwHA) Treated with Emicizumab in HAVEN 3
    Christine L. Kempton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • All-Cause and Inhibitor-Related Mortality in Non-Severe Hemophilia _ Patients in the United States
    Christine L. Kempton, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Lectures

  • Validation of Instrument to Assess Hemophilia-Related Distress 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019
  • Hematologic Emergencies 
    2019 ACP Internal Medicine Meeting, Philadelphia - 4/12/2019
  • Hemophilia: A Disease in Transition 
    60th American Society of Hematology Annual Meeting - 12/2/2018

Authored Content

  • 4 Ways I Fight BurnoutJune 2024

Press Mentions

  • Gene Therapy Reduced Risk of Excessive Bleeding for People with Hemophilia B, Early Trial Data Suggests
    Gene Therapy Reduced Risk of Excessive Bleeding for People with Hemophilia B, Early Trial Data SuggestsJuly 22nd, 2022
  • Gift from Hemophilia of Georgia Establishes Newly Renovated Bleeding and Clotting Disorders Center at Emory
    Gift from Hemophilia of Georgia Establishes Newly Renovated Bleeding and Clotting Disorders Center at EmorySeptember 13th, 2018
  • ASH 2016 – Saturday, December 3
    ASH 2016 – Saturday, December 3December 3rd, 2015

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Christine Kempton, Dr. Christine Kempton, MD, Dr. C Kempton, Dr. Christine L Kempton